These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2108491)
21. Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response. Fukui I; Kihara K; Sekine H; Tachibana Y; Kawai T; Ishiwata D; Oshima H Cancer Chemother Pharmacol; 1992; 30 Suppl():S37-40. PubMed ID: 1394814 [TBL] [Abstract][Full Text] [Related]
22. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993). Oosterlinck W; Kirkali Z; Sylvester R; da Silva FC; Busch C; Algaba F; Collette S; Bono A Eur Urol; 2011 Mar; 59(3):438-46. PubMed ID: 21156335 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer. Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400 [TBL] [Abstract][Full Text] [Related]
24. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
25. Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer. Burk K; Kurth KH; Newling D Prog Clin Biol Res; 1989; 303():423-34. PubMed ID: 2780657 [No Abstract] [Full Text] [Related]
26. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design. Zincke H; Benson RC; Hilton JF; Taylor WF J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685 [TBL] [Abstract][Full Text] [Related]
27. Renal failure after intravesical mitomycin C. Farha AJ; Krauss DJ Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290 [TBL] [Abstract][Full Text] [Related]
28. 5-year experience with intravesical therapy of carcinoma in situ: an inquiry into the risks of "conservative" management. Stanisic TH; Donovan JM; Lebouton J; Graham AR J Urol; 1987 Nov; 138(5):1158-61. PubMed ID: 3118055 [TBL] [Abstract][Full Text] [Related]
29. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response]. Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621 [No Abstract] [Full Text] [Related]
30. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors. Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S Cancer Chemother Pharmacol; 1987; 20 Suppl():S52-5. PubMed ID: 3117399 [TBL] [Abstract][Full Text] [Related]
31. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. Soloway MS; Jordan AM; Murphy WM Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268 [TBL] [Abstract][Full Text] [Related]
32. Intravesical mitomycin C and superficial bladder tumors. Biserte J; Rigot JM; Mauroy B; Mazeman E Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555 [No Abstract] [Full Text] [Related]
33. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?]. Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder. Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274 [TBL] [Abstract][Full Text] [Related]
35. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. Harrison GS; Green DF; Newling DW; Richards B; Robinson MR; Smith PH Br J Urol; 1983 Dec; 55(6):676-9. PubMed ID: 6418263 [TBL] [Abstract][Full Text] [Related]
36. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project. Friedell GH Cancer Chemother Pharmacol; 1983; 11 Suppl():S13-5. PubMed ID: 6416697 [TBL] [Abstract][Full Text] [Related]
37. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe? Droller MJ; Walsh PC J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686 [TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study. Boccardo F; Cannata D; Rubagotti A; Guarneri D; Decensi A; Canobbio L; Curotto A; Martorana G; Pegoraro C; Selvaggi F J Clin Oncol; 1994 Jan; 12(1):7-13. PubMed ID: 8270987 [TBL] [Abstract][Full Text] [Related]
39. Management of superficial bladder cancer in a community setting. Haas JA Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328 [TBL] [Abstract][Full Text] [Related]
40. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports]. Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]